Mylan Can Face Hatch-Waxman Suit In Del., Fed. Circ. Hears
AstraZeneca AB told the Federal Circuit Thursday to affirm a ruling that Mylan Pharmaceuticals Inc. is subject to jurisdiction in Delaware in a suit over generic versions of two AstraZeneca diabetes...To view the full article, register now.
Already a subscriber? Click here to view full article